Crispr Therapeutics shares owned by Two Sigma Advisers
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Two Sigma Advisers
from 13F filings
Historical chart of Two Sigma Advisers investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Two Sigma Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $37M | 573k | 64.81 |
| 2025-06-30 | $65M | 1.3M | 48.64 |
| 2025-03-31 | $27M | 797k | 34.03 |
| 2024-12-31 | $3.3M | 85k | 39.36 |
| 2024-09-30 | $2.6M | 56k | 46.98 |
| 2023-09-30 | $436k | 9.6k | 45.39 |
| 2023-06-30 | $971k | 17k | 56.14 |
| 2021-09-30 | $25M | 221k | 111.93 |
| 2021-06-30 | $147M | 905k | 161.89 |
| 2021-03-31 | $125M | 1.0M | 121.85 |
| 2020-12-31 | $55M | 360k | 153.11 |
| 2020-09-30 | $27M | 323k | 83.64 |
| 2020-06-30 | $17M | 234k | 73.49 |
| 2020-03-31 | $9.6M | 227k | 42.41 |
| 2019-12-31 | $18M | 288k | 60.90 |
| 2019-09-30 | $2.3M | 57k | 40.99 |
| 2019-06-30 | $5.3M | 112k | 47.10 |
| 2019-03-31 | $8.6M | 239k | 35.72 |
| 2018-12-31 | $14M | 473k | 28.57 |
| 2018-09-30 | $18M | 413k | 44.35 |
| 2018-06-30 | $22M | 369k | 58.76 |
| 2018-03-31 | $1.6M | 34k | 45.70 |